QTTB - Q32 Bio Inc.

Price Target Consensus

33.25

Consensus Target

66

High Target

27

Median Target

13

Low Target

Price Target News & Updates

Date	Analyst	Company	Price Target	News Title
2026-07-13	Derek Archila	Wells Fargo	$66	Q32 Bio upgraded to Overweight at Wells Fargo after alopecia areata study data
2026-07-13	N/A	Oppenheimer	$40	Q32 Bio Inc. (QTTB) PT Raised to $40 at OppenheimerMember Login
2026-05-22	Joseph Catanzaro	Mizuho Securities	$14	Q32 Bio initiated with an Outperform at Mizuho
2026-03-10	Joseph Pantginis	H.C. Wainwright	$13	H.C. Wainwright Reiterates Buy Rating on Q32 Bio Inc. (QTTB): "2026 should be h…
2024-12-05	Etzer Darout	BMO Capital	$64	BMO Capital Starts Q32 Bio Inc. (QTTB) at Outperform
2024-10-16	Jay Olson	Oppenheimer	$80	Oppenheimer Reiterates Outperform Rating on Q32 Bio Inc. (QTTB)
2024-09-11	Derek Archila	Wells Fargo	$95	Wells Fargo Starts Q32 Bio Inc. (QTTB) at Overweight
2024-05-21	Thomas Smith	Leerink Partners	$54	Q32 Bio initiated with an Outperform at Leerink
2024-04-10	Jay Olson	Oppenheimer	$50	Oppenheimer Starts Q32 Bio Inc. (QTTB) at Outperform
2024-04-02	Christopher Raymond	Raymond James	$45	Q32 Bio initiated with an Overweight at Piper Sandler